Shares of Alkem Laboratories experienced significant volatility on Thursday, falling as much as 2.39%, or ₹129.15, to ₹5,285 during intraday trading. According to latest market data, the stock touched an intraday high of ₹5,444.90 and low of ₹5,285, with trading volumes of 2,047 shares compared to its five-day average of 17,268 shares, representing a -88.15% decrease in trading activity. The stock was trading at ₹5,307 on Thursday afternoon, reflecting the ongoing market impact of the CFO resignation announcement.
The company announced in an exchange filing on September 24 that Nitin Agrawal had resigned from his position on July 30, 2026, to pursue new professional opportunities. Agrawal will cease to hold the position of Senior Management Personnel at Alkem Laboratories effective September 30, 2026. In his resignation letter, Agrawal expressed that serving as CFO had been "a great honour" and that he would always look back on the stint with gratitude. The resignation comes as part of broader market volatility, with the stock's performance reflecting investor concerns over leadership transitions amid current market conditions.
According to the resignation letter reported by Moneycontrol, Agrawal thanked the Board of Directors for entrusting him with several strategic mandates during his tenure. These included "building the MedTech business from the ground up, the acquisition of Adroit, the creation of Alkem Wellness, the formation of the Saudi joint venture and the acquisition of Bombay Ortho." He also mentioned his role in supporting the liquidation of idle assets such as the Indore SEZ plant, enhancement of returns on treasury income, and implementation of new UCPMP marketing guidelines in the domestic market.
The stock's performance reflects broader market volatility, with the company's market capitalisation standing at ₹5,044.56 crore. Agrawal stated that "this has not been an easy decision" but chose to step down to pursue new professional opportunities that align more closely with his long-term professional and personal growth. He committed to remaining committed to supporting the management in ensuring a seamless handover of all ongoing strategic initiatives and would serve through September 30, 2026.
